ID: ALA3642164

Max Phase: Preclinical

Molecular Formula: C27H30Cl3N3O3

Molecular Weight: 550.91

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)N1CCC(C(=O)N2CC[C@@H](N(C)C(=O)c3ccc(Cl)cc3)[C@H](c3ccc(Cl)c(Cl)c3)C2)CC1

Standard InChI:  InChI=1S/C27H30Cl3N3O3/c1-17(34)32-12-9-19(10-13-32)27(36)33-14-11-25(22(16-33)20-5-8-23(29)24(30)15-20)31(2)26(35)18-3-6-21(28)7-4-18/h3-8,15,19,22,25H,9-14,16H2,1-2H3/t22-,25+/m0/s1

Standard InChI Key:  RPTJPWCOBZLMMD-WIOPSUGQSA-N

Associated Targets(Human)

Neurokinin 2 receptor 3341 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Neurokinin 1 receptor 6273 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 550.91Molecular Weight (Monoisotopic): 549.1353AlogP: 5.36#Rotatable Bonds: 4
Polar Surface Area: 60.93Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: 3.66CX LogD: 3.66
Aromatic Rings: 2Heavy Atoms: 36QED Weighted: 0.51Np Likeness Score: -1.20

References

1.  (2013)  Nitrogen-containing heterocyclic compound and use thereof, 

Source

Source(1):